These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 34845743)

  • 1. Super-resolution imaging detects BP180 autoantigen in immunoglobulin M pemphigoid.
    Hirano Y; Iwata H; Tsujuwaki M; Mai S; Mai Y; Imafuku K; Izumi K; Koga H; Ujiie H
    J Dermatol; 2022 Mar; 49(3):374-378. PubMed ID: 34845743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Case of Anti-BP180-type Mucous Membrane Pemphigoid with IgG and IgA Autoantibodies Showing Distinct Reactivities.
    Minakawa S; Matsuzaki Y; Hashimoto T; Ishii N; Nishie W; Nakazawa M; Sawamura D
    Acta Dermatovenerol Croat; 2022 Jul; 30(1):54-56. PubMed ID: 36153720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preferential Reactivity of Dipeptidyl Peptidase-IV Inhibitor-Associated Bullous Pemphigoid Autoantibodies to the Processed Extracellular Domains of BP180.
    Mai Y; Nishie W; Izumi K; Shimizu H
    Front Immunol; 2019; 10():1224. PubMed ID: 31191560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible paraneoplastic syndrome case of bullous pemphigoid with immunoglobulin G anti-BP180 C-terminal domain antibodies associated with psoriasis and primary macroglobulinemia.
    Maki N; Demitsu T; Umemoto N; Nagashima K; Nakamura T; Kakurai M; Nakamura S; Yamada T; Ishii N; Hashimoto T
    J Dermatol; 2016 May; 43(5):571-4. PubMed ID: 26507447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the combination of BP180-NC16a enzyme-linked immunosorbent assay and BP230 enzyme-linked immunosorbent assay in the diagnosis of bullous pemphigoid.
    Yang B; Wang C; Chen S; Chen X; Lu X; Tian H; Yu M; Zhang D; Shi Z; Zhou G; Zhang F
    Indian J Dermatol Venereol Leprol; 2012; 78(6):722-7. PubMed ID: 23075641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoantibodies in lichen planus pemphigoides react with a novel epitope within the C-terminal NC16A domain of BP180.
    Zillikens D; Caux F; Mascaro JM; Wesselmann U; Schmidt E; Prost C; Callen JP; Bröcker EB; Diaz LA; Giudice GJ
    J Invest Dermatol; 1999 Jul; 113(1):117-21. PubMed ID: 10417629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Normal human skin is superior to monkey oesophagus substrate for detection of circulating BP180-NC16A-specific IgG antibodies in bullous pemphigoid.
    Emtenani S; Yuan H; Lin C; Pan M; Hundt JE; Schmidt E; Komorowski L; Stanley JR; Hammers CM
    Br J Dermatol; 2019 May; 180(5):1099-1106. PubMed ID: 30315657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Case of pemphigoid vegetans with autoantibodies against the BP180 C-terminal domain and BP230 antigen.
    Doi C; Shiraishi K; Koga H; Ishii N; Sayama K
    J Dermatol; 2021 Aug; 48(8):1286-1290. PubMed ID: 34003521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A highly sensitive enzyme-linked immunosorbent assay for the detection of circulating anti-BP180 autoantibodies in patients with bullous pemphigoid.
    Zillikens D; Mascaro JM; Rose PA; Liu Z; Ewing SM; Caux F; Hoffmann RG; Diaz LA; Giudice GJ
    J Invest Dermatol; 1997 Nov; 109(5):679-83. PubMed ID: 9347799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a BP180-NC16a enzyme-linked immunosorbent assay in the initial diagnosis of bullous pemphigoid.
    Sakuma-Oyama Y; Powell AM; Oyama N; Albert S; Bhogal BS; Black MM
    Br J Dermatol; 2004 Jul; 151(1):126-31. PubMed ID: 15270881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum levels of IgE anti-BP180 and anti-BP230 autoantibodies in patients with bullous pemphigoid.
    Ishiura N; Fujimoto M; Watanabe R; Nakashima H; Kuwano Y; Yazawa N; Echigo T; Okochi H; Tamaki K
    J Dermatol Sci; 2008 Feb; 49(2):153-61. PubMed ID: 17920818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Case of Possible Concurrence of Dermatitis Herpetiformis and Linear Immunoglobulin A / Immunoglobulin G Bullous Dermatosis.
    Minakawa S; Matsuzaki Y; Hashimoto T; Ishii N; Nishie W; Sawamura D
    Acta Dermatovenerol Croat; 2021 Jul; 29(2):116-117. PubMed ID: 34477081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective study in bullous pemphigoid: association of high serum anti-BP180 IgG levels with increased mortality and reduced Karnofsky score.
    Holtsche MM; Goletz S; van Beek N; Zillikens D; Benoit S; Harman K; Walton S; English J; Sticherling M; Chapman A; Levell NJ; Groves R; Williams HC; König IR; Schmidt E;
    Br J Dermatol; 2018 Oct; 179(4):918-924. PubMed ID: 29607480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relapse-associated autoantibodies to BP180 in a patient with anti-p200 pemphigoid.
    Kasperkiewicz M; Hoppe U; Zillikens D; Schmidt E
    Clin Exp Dermatol; 2010 Aug; 35(6):614-7. PubMed ID: 19874345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BPDAI and ABSIS correlate with serum anti-BP180 NC16A IgG but not with anti-BP230 IgG in patients with bullous pemphigoid.
    Daneshpazhooh M; Ghiasi M; Lajevardi V; Nasiri N; Balighi K; Teimourpour A; Khosravi H; Saeidi V; Mahmoudi H; Chams-Davatchi C
    Arch Dermatol Res; 2018 Apr; 310(3):255-259. PubMed ID: 29423547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BP180 as the common autoantigen in blistering diseases with different clinical phenotypes.
    Zillikens D
    Keio J Med; 2002 Mar; 51(1):21-8. PubMed ID: 11951375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoglobulin M pemphigoid.
    Boch K; Hammers CM; Goletz S; Kamaguchi M; Ludwig RJ; Schneider SW; Zillikens D; Hadaschik E; Schmidt E
    J Am Acad Dermatol; 2021 Dec; 85(6):1486-1492. PubMed ID: 33453342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of Diagnostic Strategy for Early Recognition of Bullous and Nonbullous Variants of Pemphigoid.
    Meijer JM; Diercks GFH; de Lang EWG; Pas HH; Jonkman MF
    JAMA Dermatol; 2019 Feb; 155(2):158-165. PubMed ID: 30624575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of IgG subclasses and complement deposition in BP230-type bullous pemphigoid.
    Zheng M; Ujiie H; Iwata H; Muramatsu K; Yoshimoto N; Ito T; Ujiie I; Shimizu S; Sato-Matsumura KC; Shimizu H
    J Eur Acad Dermatol Venereol; 2019 Mar; 33(3):595-600. PubMed ID: 30394605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Linear IgA dermatosis with IgA and IgG autoantibodies to the 180 kDa bullous pemphigoid antigen (BP180): evidence for a distinct subtype.
    Metz BJ; Ruggeri SY; Hsu S; Reed JA; Ghohestani AS; Uitto J; Ghohestani RF
    Int J Dermatol; 2004 Jun; 43(6):443-6. PubMed ID: 15186228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.